Exemestane Aromasin Privateraws Raw Steroid Powder

Exemestane/ Aromasin
Product name :Exemestane
Synonym: Aromasin
Appearance :White crystalline powder
Purity :98%min
CAS: 107868-30-4
Molecular formula :C20H24O2
Molecular weight :296.4
Minimum order :10g
Usage :Aromasin is a very strong and very potent steroidal aromatase inhibitor of the suicidal type, and information within the packaging in prescription Aromasin describes the ability for Aromasin to reduce Estrogen levels by 85%, as evidenced by studies on breast cancer patients. Suicidal aromatase inhibitors such as Aromasin (Exemestane) serve to permanently inhibit and disable the aromatase enzyme to which it is bound to. This renders the enzyme inactive forever. The body will eventually manufacture more aromatase enzymes, but the currently bound enzymes are bound indefinitely, eliminating any risk for Estrogen rebound. This is unseen with the other two major aromatase inhibitors (Arimidex and Letrozole), which are non-suicidal aromatase inhibitors that are only bound to the aromatase enzyme for limited time periods before the aromatase inhibitors unbind and become metabolized. If a non-suicidal aromatase inhibitor is halted too abruptly, the circulating inhibited aromatase enzymes that have not been metabolized out of the body will then become free again, and begin aromatizing androgens into Estrogens at an often rapid rate. This is not the case with Aromasin .

Dosage instruction:
Aromasin Dosage During Anabolic Steroid Use

As with most/all ancillary compounds, Aromasin cannot be categorized into the three tiers of users (beginner, intermediate, and advanced) as normally outlined and listed in common profiles of the different compounds and drugs. This is due to the fact that Aromasin is an ancillary drug not particularly used for the purpose of performance enhancement, but instead is utilized to combat or mitigate various Estrogen-related side effects when aromatizable anabolic steroids are utilized.

Aromasin holds several different capabilities of use aside from its Estrogen blocking capabilities, and not only is its Estrogen blocking capabilities a step above the other major aromatase inhibitors, but its ability to increase Testosterone levels is as well. This will be covered in greater detail very shortly, under Aromasin’s use during PCT (Post Cycle Therapy).

For the purpose of Estrogen control during a cycle: It is well established that Aromasin is very effective at reducing total Estrogen levels via the inhibition of the aromatase enzyme. But how much Aromasin is required and how often are factors that are largely dependent on the doses of aromatizable anabolic steroids used, the individual’s sensitivity to aromatase inhibitors, and the rate of aromatization of the anabolic steroids used. With this being said, the general range of Aromasin doses are 12.5 – 1mg daily. As with all aromatase inhibitors, there is always room for adjustment in relation to the user’s experiences at a particular Aromasin dose and dose frequency. Often times, adjustment is necessary with a powerful and very potent aromatase inhibitor such as Aromasin. Aromasin dosages of 12.5mg every other day is enough for Estrogen control, which is commonly utilized among the anabolic steroid using community. Once again, adjustments are a normal part of aromatase inhibitor use.

It is very important for the reader to be reminded to always keep in mind that the use of an aromatase inhibitor is for the purpose of Estrogen control in order to restore circulating Estrogen levels back to normal physiological levels following an increase due to aromatization. Complete reduction and/or elimination of Estrogen levels often result in negative effects on the body.

Female Aromasin Dosage

Female anabolic steroid users seldom need to worry about rising Estrogen levels, but for those that are competitive bodybuilders that must eliminate the water retention associated with Estrogen that causes the unwanted bloating, the use of an aromatase inhibitor such as Aromasin (Exemestane) might be necessary. It is important to remember that medically, Aromasin is approved for use in post-menopausal females only, who possess a very different shift in hormone levels compared to pre-menopausal females. Because medical data has suggested that aromatase inhibitors are far more effective in females than males (depending on the aromatase inhibitor in question used), Aromasin doses of 12.5mg every other day or once every two days should suffice and in fact often times become too much, in which case the individual might feel the need to adjust to either a lower dose or a lesser frequency of administration.

Aromasin Dosage for Increased Endogenous Testosterone Secretion and PCT (Post Cycle Therapy)

It is very clear that Aromasin can increase Testosterone levels in males as demonstrated by studies. One particular study selected 12 healthy young male test subjects, and were administered random Aromasin doses of 25mg and 50mg for a 10 day period, and not only was Estrogen suppressed by a significant amount (38%), but Testosterone levels in the test subjects were observed to increase by an incredible 60%[1]. Boosting the endogenous Testosterone production in men by an impressive 60% is not the only major benefit that Aromasin possesses. Aromasin also holds additional benefits that essentially make it the ‘king’ aromatase inhibitor for the purpose of HPTA and Testosterone recovery during PCT above all other aromatase inhibitors. The stimulation of endogenous Testosterone secretion is a characteristic common of all aromatase inhibitors and is due to the fact that excess Estrogen will cause a negative feedback loop response of the HPTA to initiate Testosterone suppression.

In addition to generating a considerable increase in endogenous Testosterone output, Aromasin also holds several advantages and effects over other aromatase inhibitors that do not exhibit them. For example, a common attribute of all aromatase inhibitors is the unfortunate effect of altering cholesterol levels in a very negative manner (reduction of the ‘good’ HDL cholesterol and increasing the ‘bad’ LDL cholesterol). This is due in large part to the drop in Estrogen levels, as well as the aromatase inhibitor’s actions themselves. Aromasin has demonstrated in several studies that it impacts cholesterol profiles far less than other aromatase inhibitors have, where in one particular study on cancer patients, 24 weeks of Aromasin (Exemestane) administration held no impact on cholesterol profiles[2]. Some of the same studies mentioned have also demonstrated a nil effect on cholesterol profiles from the use of Aromasin[1]. However, some other studies have displayed an alteration in cholesterol values from Aromasin administration, but that it was not as significant or as negatively impacting as other aromatase inhibitors[3].

Questions AromasinIn addition to the lack of negative effects on cholesterol profiles, Aromasin has also demonstrated in the same study that linked Aromasin to an increase in endogenous Testosterone production to also un-alter serum IGF-1 levels, which is something uncommon among aromatase inhibitors1. At its worst, it may lower IGF-1 levels slightly, which is a significant difference from all other aromatase inhibitors, and Aromasin has also been found to lower concentrations of IGF-1 binding protein-3 (a protein that binds to and inhibits IGF-1)1. This is all very good information to the anabolic steroid using athlete who wishes to recover efficiently and quickly during the PCT weeks following the termination of a cycle, as IGF-1 is very important for muscle gains. But the benefits of Aromasin do not stop there.

There is one issue with the addition of the other two aromatase inhibitors (Arimidex and Letrozole) in a PCT program that includes the use of SERMs such as Nolvadex and Clomid, which are known as absolutely essential components to a PCT program. The problem here is that Arimidex and Nolvadex both directly counteract one another. One study has demonstrated that when Arimidex is utilized with Nolvadex, Nolvadex will decrease blood plasma concentration of Arimidex (as well as Letrozole, another commonly used aromatase inhibitor)[4]. The conclusion here is that the use of Arimidex or Letrozole with Nolvadex together is a very bad idea and may work counterproductively if used together in a PCT protocol.

Aromasin completely circumvents this problem, as it has been demonstrated to have no interactions what so ever with Nolvadex, unlike the other two aforementioned aromatase inhibitors. In one study, Aromasin displayed no reduced effectiveness, nor any reduced blood plasma levels when utilized with Nolvadex[5]. Nolvadex is also very well known for reducing blood plasma levels of IGF-1 during use[6]. This might possibly indicate that Aromasin may assist to maintain stable IGF-1 levels or at the very least do nothing to further worsen Nolvadex’s effects on IGF-1. Therefore, from all of the information gathered, Aromasin and Nolvadex when utilized together for PCT are very complimentary with one another, making Aromasin the absolute best aromatase inhibitor not only for general use but also for HPTA recovery during PCT (or at any other time).

A sufficient Aromasin dosage for HPTA recovery during PCT would be 25mg daily for no longer than a 2 week period while Nolvadex would be utilized for a total of 4 weeks at 20 – 40mg daily.

Your Name

Your Email

Inquiry Product

Your Message